Katkin Keith (CIK 0001314596)

Latest company ownership

Shares held
100,000
Last filed at
May 19, 2025
Confidence Score
52.1
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
86,431
Last filed at
May 28, 2025
Confidence Score
49.2
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 23, 2025 May 28, 2025 Emergent BioSolutions Inc. Director Sell 32.5 -7,844 -8.32% $49.4K
May 19, 2025 May 19, 2025 Syndax Pharmaceuticals Inc Director Buy 95.0 +10,000 11.11% $91.1K
Oct 6, 2022 Oct 7, 2022 Syndax Pharmaceuticals Inc Director Sell 7.5 -29,899 -31.84% $774.4K
Sep 30, 2022 Oct 4, 2022 Syndax Pharmaceuticals Inc Director Sell 41.3 -4,101 -2.09% $102.8K